Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-04-05
1992-10-20
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514311, 514314, 514 82, 5142308, 546153, 546168, 546171, 546 23, 546155, 546156, 546 14, 544 97, 548250, A61K 3147, C07D40110
Patent
active
051570408
ABSTRACT:
Substituted quinolines of the formula (I), are angiotensin II antagonists, ##STR1## and useful in the treatment of hypertension, ocular hypertension and certain CNS disorders.
REFERENCES:
patent: 4812463 (1989-03-01), Graham et al.
patent: 4851409 (1989-07-01), Young et al.
patent: 4868193 (1989-09-01), Lee
patent: 4904286 (1990-02-01), Musser et al.
patent: 4918081 (1990-04-01), Huang et al.
patent: 4920130 (1990-04-01), Huang et al.
patent: 4920131 (1990-04-01), Huang et al.
patent: 4920132 (1990-04-01), Huang et al.
patent: 4920133 (1990-04-01), Huang et al.
patent: 5028615 (1991-07-01), Huang et al.
patent: 5041453 (1991-08-01), Huang et al.
patent: 5059610 (1991-10-01), Huang et al.
patent: 5064825 (1991-11-01), Chakrauarty et al.
patent: 5071988 (1991-12-01), Failli
patent: 5084462 (1992-01-01), Ackerman et al.
Greenlee William J.
Johnston David B. R.
Maccoss Malcolm
Daus Donald G.
DiPrima Joseph F.
Merck & Co. , Inc.
Nicholson William H.
LandOfFree
Substituted quinolines as angiotensin II antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted quinolines as angiotensin II antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted quinolines as angiotensin II antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-192323